News & Perspective

Oct 03, 2016

Oct 03, 2016

News Scan for Oct 03, 2016

MRSA in UK pork
Online antibiotic Rx
Chikungunya increase
Anthrax vaccine funds
Yellow fever vaccine

Apr 15, 2016

Apr 15, 2016

News Scan for Apr 15, 2016

Ebola vaccine's future
More US flu deaths
US biodefense coordination
WHO dengue vaccine advice
Carbapenem resistance in Europe
Scope infections
Malaria drug resistance

Jun 11, 2015

Jun 11, 2015

News Scan for Jun 11, 2015

Flap over DHS contract move
Ghana halts Ebola vaccine trials
Zika virus case denied

Sep 09, 2014

Sep 09, 2014

News Scan for Sep 09, 2014

ICU infections in kids
Heat-tolerant anthrax vaccine
Ohio measles over
Berry-linked hepatitis
Vectorborne illness control

May 28, 2014

May 28, 2014

News Scan for May 28, 2014

WHA smallpox no-decision
Failed dengue therapy
Ultraviolet disinfection

Oct 14, 2011

Oct 14, 2011

NIH contracts target broad-spectrum therapies for bioterror threats

(CIDRAP News) – The National Institutes of Health (NIH) yesterday announced it has awarded contracts, which could total $150 million over 5 years, to four companies to develop broad-spectrum therapies that could help the nation respond to a bioterror attack or other public health emergency.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»